Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
drugs
life sciences
national blog main
new york
new york blog main
new york top stories
akcea therapeutics
alirocumab
alnylam pharmaceuticals
amgen
anylam pharmaceuticals
biotech
boston top stories
cardiomyopathy
evercore isi
evolocumab
heart attack
inclisiran
inotersen
joseph swartz
medicines co.
national top stories
neuropathy
onpattro
patisiran
pcsk9 inhibitors
pfizer
regeneron pharmaceuticals
rna interference
san diego blog main
san diego top stories
stroke
svb leerink
tafamidis
tegsedi
transthyretin amyloidosis
umer raffat
What
alnylam
2
×
drug
medicines
2
×
ago
akcea
amyloidosis
approved
attr
available
based
battle
cholesterol
data
debilitating
disease
evidence
fda
genetic
heart
lasting
long
looms
lowering
medco
new
oks
partner
patients
pfizer
pharmaceuticals
presented
rare
reckoning
rna
sets
supporting
term
touts
transthyretin
use
Language
Current search:
alnylam
×
medicines
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
